# Long-term extension data do not robustly support clinical disease course modification with donanemab

**Authors:** Jemma Hazan, Kathy Y. Liu, Robert Howard

PMC · DOI: 10.1016/j.tjpad.2026.100511 · The Journal of Prevention of Alzheimer's Disease · 2026-02-20

## Full-text entities

- **Diseases:** AD (MESH:D000544), dementia (MESH:D003704)
- **Chemicals:** Donanemab (-), memantine (MESH:D008559)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945568/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945568/full.md

---
Source: https://tomesphere.com/paper/PMC12945568